Genotech Pharmaceuticals Private Limited

Genotech Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2010PTC068845 Incorporated 07 June 2010 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹25.44 Lakh
▼ 72% YoY
Net loss · FY 2025
₹21.85 Lakh
Net margin -85.9%
EBITDA · FY 2025
-₹5.14 Lakh
EBITDA margin -20.2%
Authorised capital
₹32 Lakh
Registered with MCA
Paid-up capital
₹32 Lakh
Issued & subscribed
Open charges
₹30 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
4
As per MCA filings

About Genotech Pharmaceuticals Private Limited

Data last updated:

Genotech Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC068845. Its GSTIN is 36AAECG0057A1Z8 (Telangana).

The company has an authorised share capital of ₹32 Lakh and a paid-up capital of ₹32 Lakh. It is led by directors including Thaduri Srivani and Ravi Kumar Pericherla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No: 8 – 16 – 26/1 Sowbhagyanagar Colony L.B.Nagar Saroornagar, Hyderabad, Telangana, India – 500040.

As per the financials filed for FY 2025, the company reported a revenue of ₹25.44 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net loss of ₹21.85 Lakh (net margin -85.9%) and EBITDA of -₹5.14 Lakh (EBITDA margin -20.2%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 42% over five years.

As per MCA filings, the company has open charges of ₹30 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.

Genotech Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0004618). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genotechpharma.com.

Company details

CIN U24232TG2010PTC068845
Registration Number 068845
Incorporation Date 07 June 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0004618

CIN history

Genotech Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2010PTC068845. The current CIN is U24232TG2010PTC068845, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2010PTC068845Current
U24232AP2010PTC068845Previous

Recognitions & Rankings of Genotech Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-09-0004618

Contact details

Genotech Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is genotechpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    D.No: 8 – 16 – 26/1 Sowbhagyanagar Colony L.B.Nagar Saroornagar, Hyderabad, Telangana, India – 500040
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Genotech Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Genotech Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Genotech Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Genotech Pharmaceuticals Private Limited, buy the company report.

Financials of Genotech Pharmaceuticals Private Limited

FY 2024 filings available

Genotech Pharmaceuticals Private Limited reported revenue of ₹25.44 Lakh (down 72% YoY) for FY 2025.

Revenue · FY 2025
₹25.44 Lakh ▼ 72%
Net loss · FY 2025
₹21.85 Lakh margin -85.9%
EBITDA · FY 2025
-₹5.14 Lakh margin -20.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 72%
3 years · compounded
▼ 65%
5 years · compounded
▼ 42%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▼ 28%
5 years · compounded
▼ 16%

Revenue has declined at a compounded annual rate (CAGR) of 42% over five years, including a 72% fall in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.14 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹21.85 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-20.2%
Net Profit Margin-85.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Genotech Pharmaceuticals Private Limited, buy the company report.

Board of directors of Genotech Pharmaceuticals Private Limited

Genotech Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Thaduri SrivaniDirector25 May 20215 Years 4 MonthsCurrent
Ravi Kumar PericherlaDirector13 Jul 20188 Years 3 MonthsCurrent
Murari RajakumariDirector25 May 20215 Years 4 MonthsCurrent
Suryanarayana KolaganiDirector15 Jun 20188 Years 4 MonthsCurrent

Auditor

Genotech Pharmaceuticals Private Limited is audited by NAGELLA & COMPANY LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
NAGELLA & COMPANY LLPFY 2023S200031

Shareholding

The shareholding of Genotech Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Genotech Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹30 Lakh
Satisfied charges
None
Breakdown by lending institutions
Dhanlaxmi Bank Limited₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Feb 2017100081761Dhanlaxmi Bank Limited₹30 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Genotech Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Genotech Pharmaceuticals has 3 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Associated companies

GST

Genotech Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAECG0057A1Z8TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Genotech Pharmaceuticals Private Limited, buy the company report.

Recent activity

Genotech Pharmaceuticals Private Limited has 8 board changes on record since 2018: 4 appointments and 4 cessations. The latest: Murari Rajakumari was appointed as Director on 25 May 2021.

AGM
Genotech Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genotech Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Murari Rajakumari was appointed as Director.
Appointed
Thaduri Srivani was appointed as Director.
Ceased
Murari Venkateswara Rao ceased to be Director.
Ceased
Mudunuru Raju Sasikumar ceased to be Director.
Ceased
Ravi Kumar Pericherla ceased to be Alternate Director.
Ceased
Suryanarayana Kolagani ceased to be Alternate Director.
Appointed
Ravi Kumar Pericherla was appointed as Director.
Appointed
Suryanarayana Kolagani was appointed as Director.
Charges
A charge with Dhanlaxmi Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 100081761 was registered on 08 Feb 2017.
Incorporation
07 Jun 2010
Genotech Pharmaceuticals Private Limited was registered on 07 Jun 2010 with Roc Hyderabad & aged 16 years 4 months as per MCA records.

Frequently asked questions

Genotech Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2010 (16+ years old) and is registered under CIN U24232TG2010PTC068845.

Genotech Pharmaceuticals has 4 current directors:

The latest financial statements of Genotech Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Genotech Pharmaceuticals is 36AAECG0057A1Z8, registered in Telangana.

The CIN (Corporate Identification Number) of Genotech Pharmaceuticals is U24232TG2010PTC068845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Genotech Pharmaceuticals has 1 court case on record: 1 filed against it.

Genotech Pharmaceuticals was incorporated on 07 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.

Murari Rajakumari was appointed as Director on 25 May 2021. Thaduri Srivani was appointed as Director on 25 May 2021. Murari Venkateswara Rao ceased to be Director on 14 Jan 2021. Genotech Pharmaceuticals has 8 board changes on record in total.

Yes, Genotech Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0004618).

Genotech Pharmaceuticals can be reached through the website genotechpharma.com. Its registered office is in Hyderabad, Telangana, India.